Novartis Zelnorm DTC Ads To Start In Fall; Resources Shifted From Field Force
Executive Summary
Novartis plans to launch a national DTC campaign for its irritable bowel syndrome agent Zelnorm early in the third quarter, the company announced during its July 21 investor conference call